Valneva SE

Common Name
Valneva
Country
France
Sector
Healthcare
Industry
Biotechnology
Employees
700
Ticker
VLA
Exchange
EURONEXT
Description
Valneva SE is a European biotechnology company specializing in vaccine development and production. The company focuses on developing promising prophylactic vaccines aimed at combating infectious disea...

Valneva's GHG Emissions Data Preview

In 2024, Valneva completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Valneva has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Valneva’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Valneva’s data sources below and access millions more through our Disclosure Search.

a. Valneva's Sustainability Report 2024
a. Valneva's Sustainability Report 2024

Insights into Valneva's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Valneva amounted to 3,776 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Valneva decreased by 0.87%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Valneva's Scope 1 Emissions Over Time

2022202405001 k1.5 k2 ktCO2e-32%
  • Total Scope 1
  • Year-over-Year Change

What are Valneva's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Valneva were 1,277 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2022), Valneva's Scope 1 emissions decreased by 32.43%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Valneva's Scope 2 emissions?

In 2024, Valneva reported Scope 2 greenhouse gas (GHG) emissions of 2,499 tCO₂e using the location-based method. a

Has Valneva reduced its Scope 2 emissions over time?

Compared to the previous year (2022), Valneva's Scope 2 emissions (Location-Based) rose by 30.22% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a

What methodology does Valneva use for Scope 2 reporting?

In 2024, Valneva reported its Scope 2 emissions using the location-based method. a

Valneva's Scope 2 Emissions Over Time

2022202406501.3 k1.95 k2.6 ktCO2e
  • Total Scope 2 Location-Based

Insights into Valneva's Value Chain Emissions

In 2024, Valneva reported 55,534 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Valneva includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2022, reflecting improved emissions accounting practices and greater transparency across the company's value chain a

Valneva's Scope 3 Emissions Over Time

2024015 k30 k45 k60 ktCO2e
  • Total Scope 3
  • Year-over-Year Change

What are Valneva's Scope 3 emissions?

In 2024, Valneva reported total Scope 3 emissions of 55,534 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 98.56% of these emissions originated from upstream activities such as purchased goods and capital goods, while 1.44% came from downstream activities like product use, distribution, and end-of-life treatment. a

What categories of Scope 3 emissions does Valneva disclose?

In 2024, Valneva reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Valneva's Scope 3 emissions?

In 2024, the largest contributors to Valneva's Scope 3 emissions were: a

  • Purchased Goods and Services (Cat. 1): 34,964 tCO₂e (62.96%)
  • Upstream Transportation and Distribution (Cat. 4): 9,044 tCO₂e (16.29%)
  • Downstream Transportation and Distribution (Cat. 9): 5,791 tCO₂e (10.43%)

Valneva's Scope 3 Emissions by Categories

UpstreamTransportation andDistribution(Cat. 4)(16.3%)DownstreamTransportation andDistribution(Cat. 9)(10.4%)Purchased Goods andServices (Cat. 1)(63.0%)

Insights into Valneva’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Valneva reported Scope 1 greenhouse gas (GHG) emissions of 1,277 tCO₂e and total revenues of USD 176 millions. This translates into an emissions intensity of 7.24 tCO₂e per millions USD. a

Valneva's Scope 1 Emissions Intensity Compared to Peers

0.51020010,000200,000Scope 1 Emissions (tCO2e)2201001,0005,000Revenues (Millions of USD)BLCSInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MPharma MarYear: 2023Scope 1: 1,233 tCO2eRevenue: $M 175Scope 1 Intensity: 7.04 tCO2e/$MBBBlue Jet HealthcareYear: 2025Scope 1: 23,877 tCO2eRevenue: $M 120Scope 1 Intensity: 198.82 tCO2e/$MEverest MedicinesYear: 2023Scope 1: 0 tCO2eRevenue: $M 19Scope 1 Intensity: 0.02 tCO2e/$MPeptiDreamYear: 2023Scope 1: 3,156 tCO2eRevenue: $M 203Scope 1 Intensity: 15.55 tCO2e/$MLLLigaChem BiosciencesYear: 2023Scope 1: 308 tCO2eRevenue: $M 27Scope 1 Intensity: 11.53 tCO2e/$MCCConcord BiotechYear: 2025Scope 1: 13 tCO2eRevenue: $M 138Scope 1 Intensity: 0.09 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MBiotestYear: 2020Scope 1: 18,574 tCO2eRevenue: $M 384Scope 1 Intensity: 48.41 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MSamsung BiologicsYear: 2023Scope 1: 69,262 tCO2eRevenue: $M 2,891Scope 1 Intensity: 23.96 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$MAscendis PharmaYear: 2024Scope 1: 62 tCO2eRevenue: $M 443Scope 1 Intensity: 0.14 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MAdimmuneYear: 2023Scope 1: 4,556 tCO2eRevenue: $M 58Scope 1 Intensity: 78.30 tCO2e/$MGubraYear: 2023Scope 1: 6 tCO2eRevenue: $M 30Scope 1 Intensity: 0.20 tCO2e/$MCelltrionYear: 2024Scope 1: 27,147 tCO2eRevenue: $M 2,424Scope 1 Intensity: 11.20 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2023Scope 1: 46,854 tCO2eRevenue: $M 1,101Scope 1 Intensity: 42.55 tCO2e/$MWuXi Biologics (Cayman)Year: 2023Scope 1: 32,687 tCO2eRevenue: $M 2,603Scope 1 Intensity: 12.56 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MGenor Biopharma HoldingsYear: 2022Scope 1: 18 tCO2eRevenue: $M 3Scope 1 Intensity: 7.17 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MZealand PharmaYear: 2024Scope 1: 145 tCO2eRevenue: $M 9Scope 1 Intensity: 16.60 tCO2e/$MValnevaYear: 2024Scope 1: 1,277 tCO2eRevenue: $M 176Scope 1 Intensity: 7.24 tCO2e/$M

How does Valneva's GHG emissions intensity compare to its peers?

In 2024, Valneva reported a Scope 1 emissions intensity of 7.24 tCO₂e per millions USD. Compared to the peer group median of 11.53 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Valneva rank on GHG emissions intensity within its industry?

In 2024, Valneva ranked 11 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Valneva is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Insights into Valneva's Total Carbon Footprint

In 2024, Valneva reported a total carbon footprint of 59,310 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 1,457.1% increase compared to 2022, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Valneva's total carbon footprint was Scope 3 emissions, accounting for 93.63% of the company's total carbon footprint, followed by Scope 2 emissions at 4.21%. a

Want Full Access to Valneva's GHG Emissions Dataset?
Sign Up